1247827

Howard J. Rubenstein, MD — FEI 3014666772

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 22, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Saraland, AL (United States)

Additional Details

Clinical Investigator (CI)